Neumora Therapeutics, Inc.
NMRA
$1.20
-$0.05-4.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -46.30% | -41.02% | -40.66% | -49.74% | -41.45% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 51.10% | 47.95% | 52.11% | -8.72% | 39.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -43.98% | -39.80% | -39.33% | -49.20% | -44.04% |
|
|
|||||
| Total Current Assets | -43.98% | -39.80% | -39.33% | -49.20% | -44.04% |
| Net Property, Plant & Equipment | -47.90% | -79.28% | -84.33% | -85.90% | -87.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -82.21% | -- | -- | -- | -75.43% |
| Total Assets | -44.04% | -40.07% | -39.73% | -49.56% | -44.66% |
|
|
|||||
| Total Accounts Payable | 543.94% | 380.70% | 2.18% | -91.01% | -40.48% |
| Total Accrued Expenses | 0.05% | -14.57% | 17.06% | 9.77% | 10.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 74.85% | -68.98% | -84.67% | -90.67% | -95.26% |
| Total Finance Division Other Current Liabilities | 3,386.36% | 1,804.92% | -- | -58.65% | -33.83% |
| Total Other Current Liabilities | 3,386.36% | 1,804.92% | -- | -58.65% | -33.83% |
| Total Current Liabilities | 31.30% | 6.10% | 8.58% | -18.59% | -8.51% |
|
|
|||||
| Total Current Liabilities | 31.30% | 6.10% | 8.58% | -18.59% | -8.51% |
| Long-Term Debt | 172.03% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -87.91% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 97.16% | 193.11% | 191.48% | 43.63% | 76.38% |
|
|
|||||
| Common Stock & APIC | 5.95% | 5.20% | 4.36% | 3.95% | 4.47% |
| Retained Earnings | -19.92% | -21.91% | -25.01% | -26.60% | -30.90% |
| Treasury Stock & Other | -- | -- | -- | -91.43% | 91.98% |
| Total Common Equity | -75.66% | -69.05% | -63.82% | -58.79% | -52.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -75.66% | -69.05% | -63.82% | -58.79% | -52.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -75.66% | -69.05% | -63.82% | -58.79% | -52.03% |
|
|
|||||